approval
saveIMITREX (SUMATRIPTAN) — FDA approval
community read0 votes
Sponsor: GLAXOSMITHKLINE. Form: SPRAY. Route: NASAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025 · 296d ago
- approvalIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025 · 296d ago
- approvalIMITREX (SUMATRIPTAN) — FDA approvalDec 9, 2025 · 296d ago
- approvalSUMATRIPTAN SUCCINATE — FDA approvalNov 6, 2025 · 329d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 20, 2021 · 1746d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalMar 23, 2021 · 2018d ago
- approvalIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalMar 23, 2021 · 2018d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalJul 17, 2018 · 2998d ago
same company · ±60 days · 6
- approvalSUMATRIPTAN SUCCINATE: IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalJul 21, 2010
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN) — FDA approvalJul 21, 2010
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN) — FDA approvalJul 21, 2010
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalAug 11, 2010
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalAug 11, 2010
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalAug 11, 2010
comments(0)
5-min edit window · permanent after that